ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

NIH to build cancer genome atlas

December 19, 2005 | APPEARED IN VOLUME 83, ISSUE 51

Collins
[+]Enlarge
8351gcon_collins_tifcxd.jpg

The National Cancer Institute and the National Human Genome Research Institute (NHGRI) have begun a comprehensive effort to understand the molecular basis of cancer using genome-analysis techniques. A three-year, $100 million pilot program was announced on Dec. 13 to determine the feasibility of creating a systematic atlas of genomic changes involved in all types of human cancer. The initial project will study the science and technology framework needed to identify the genetic mutations and other changes associated with cancer. It will involve only a few types of cancer for evaluating the feasibility of the larger scale program. Francis S. Collins, director of NHGRI, said it is time for such a program. "Given the genetic complexity of cancer, we are certain to face many daunting challenges in this pilot. By pulling together some of the best minds in the cancer and genomics research communities, I am confident the pilot will succeed," he said. Much of the initial research will focus on new technology development for genome analysis and will emphasize new approaches such as epigenomics-the impact of small groups on gene function-in cancer causation.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment